The Effect Of Tropical Fruits In Patients With Primary Glaucoma

A Randomized Controlled Trial Of The Effect Of Tropical Fruits On Intraocular Pressure And Retinal Nerve Fibre Layer Thickness In Patients With Primary Glaucoma

To evaluate the effect of regular tropical fruits intake in primary glaucoma patients.

Methodology :

Research Design Randomized controlled trial

Study Duration February 2024-June 2025

Study Location

1. Ophthalmology Clinic, Hospital Universiti Sains Malaysia, Kelantan

Source Reference Population Adults with primary glaucoma in Peninsular Malaysia

Study Source Population Adults with primary glaucoma attending Ophthalmology clinic, Hospital Universiti Sains Malaysia during study duration.

Study Overview

• Status: Recruiting
• Conditions: Primary Glaucoma
• Intervention / Treatment: Other: Tropical fruits

Detailed Description

General objective To evaluate the effect of regular tropical fruits intake on intra-ocular pressure (IOP) and retinal nerve fibre layer thickness (RNFL) in primary glaucoma patients.

Research hypothesis

1. There is a significant different in the IOP measurement between those whose taking regular tropical fruits and not taking them at baseline, 1 month, 3 month and 6 month among patients with primary glaucoma.
2. There is a significant different in RNFL thickness between those whose taking regular tropical fruits and not taking them at baseline, 1 month, 3 month and 6 month among patients with primary glaucoma.

Inclusion Criteria

1. Patient with confirmed diagnosis of POAG and PACG
2. Patient on medical treatment and achieved target IOP in last 6 months
3. Good compliance with pressure lowering agents

Exclusion Criteria

1. Poorly controlled diabetes mellitus, hypertension and hyperlipidaemia
2. Active smoker
3. Mentally challenge based on diagnosis
4. History of previous intraocular surgery other than uncomplicated cataract surgery within past 6 months
5. Poor signal strength OCT RNFL
6. Patient with media opacities that affect the reliability of OCT measurements , such as Cornea opacity, dense cataract with LOCS III of more than grade 2, vitreous haemorrhage
7. Other optic neuropathy apart from glaucoma
8. History of taking antioxidant supplement 3 months prior to recruitment.

Methods of Data Collection

This study will be conducted after obtaining ethical approval from the Universiti Sains Malaysia Ethical Committee (JPeM) and will be conducted in accordance to World Medical Association Declaration of Helsinki ethical principles for medical research involving human subjects.

Recruitment of Subject

Patient diagnosed with POAG and PACG attending Ophthalmology clinic, Hospital USM during study duration and fulfilled study inclusion and exclusion criteria. An informed and written consent will be taken and information form given to patients. The selected patients will be randomized into 2 groups (A and B) using sequentially numbered, opaque sealed envelopes (SNOSE). Group A patient will be consuming the chosen fruits and group B patient will not consume them.

Interventional Protocol

Patients in Group A will have to consume 2 types of fresh fruits per week as 2 servings once per day, daily for a 6-month duration. The chosen fruits are papaya, banana, mango and orange, and 2 types of fruits per week will be determined by the primary investigator. Size of the servings is according to the Malaysian Dietary Guideline 2020. They must eat them raw, and not to process or cook them in any other way. The fruits will be distributed by research assistant weekly throughout the study period. Patient will be reminded weekly using text messages or phone call by a research assistant for the fruit's consumption. Patients in group A and group B will be given a dietary diary throughout the study period, where the patient will mark the intake of fruits listed. The purpose of the diary is also to monitor patient intake of the fruits and daily diet as well.

IOP measurement

IOP measurement will be done using Goldmann Applanation Tonometer (GAT) in sitting position by the primary investigator (Nurul Munirah) who will be blinded. GAT will be calibrated daily before use to measure the IOP. Measurement of IOP will be done only at 8am - 10am (to prevent diurnal variation). Before IOP measurement, subjects are advised to avoid drinking coffee or any caffeinated drink 24 hours before and only to take light meal 2 hours before (to reduce the effect of hyperglycaemia and hydration on IOP). Only one eye will be measured, if both eyes are eligible, only right eye will be selected regardless of severity of glaucoma. Three readings of IOP will be measured and the mean reading will be taken as result. IOP measurement will be taken at baseline, first, third and sixth month post recruitment for group A and B.

OCT evaluation on RNFL thickness

Spectral domain Cirrus HD-OCT will be used to measure RNFL thickness and ONH parameters by a trained personnel who is blinded. Patient's eye will be dilated and patient will sit and rest his/her head on a support to keep it motionless in front of the OCT machine. The OCT will then scan patient's eye without touching it. Scans with signal strength less than 6, eye movement or blinking artifacts within the 1.73-mm radius around the ONH, or with segmentation errors will be repeated. If there is unsatisfactory measurement after 3 attempts, the patient will be excluded from the study. OCT will be conducted at baseline, first, third and sixth month post recruitment for group A and B.

Data Entry and Statistical Analysis

The data entry and analysis will be performed by using Statistical Package for the Social Sciences (SPSS) version 29 licensed to USM.

• Paired T-test
• Chi-square test
• A one-way repeated measures analysis of variance (RM ANOVA)

Plans for minimizing study errors

These steps will be taken to minimize the errors while conducting the study:

• The same instruments and equipment will be used for repeated measurement in this study.
• The measurement of IOP will be done at the same time (8am-10am) in a day for all patients (to prevent diurnal variation).
• OCT measurements will be performed by qualified and trained personnel only.

• Study Type: Interventional
• Enrollment (Estimated): 102
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Nurul Munirah Mohamad, Dr; Phone Number: +60105755517; Email: nurulmunirah8987@gmail.com
• Study Contact Backup: Name: Liza Sharmini Ahmad Tajudin, Prof. Dr.; Phone Number: +60199179227; Email: liza@usm.my

Study Locations

• Malaysia
  • Kota Bharu
    • Kubang Kerian, Kota Bharu, Malaysia, 16150
      • Recruiting
      • Univerisiti Sains Malaysia
      • Contact: Nurul Munirah Mohamad, MBBCh; Phone Number: +60105755518; Email: numunimo89@gmail.com
      • Principal Investigator: NURUL MUNIRAH MOHAMAD, MBBCh
      • Sub-Investigator: PROF DR LIZA SHARMINI AHMAD TAJUDIN
      • Sub-Investigator: ASS PROF DR ROHANA ABD JALIL

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

1. Patient with confirmed diagnosis of POAG and PACG
2. Patient on medical treatment and achieved target IOP in last 6 months
3. Good compliance with pressure lowering agents

Exclusion Criteria:

1. Poorly controlled diabetes mellitus, hypertension and hyperlipidaemia
2. Active smoker
3. Mentally challenge based on diagnosis
4. History of previous intraocular surgery other than uncomplicated cataract surgery within past 6 months
5. Poor signal strength OCT RNFL
6. Patient with media opacities that affect the reliability of OCT measurements , such as Cornea opacity, dense cataract with LOCS III of more than grade 2, vitreous haemorrhage
7. Other optic neuropathy apart from glaucoma
8. History of taking antioxidant supplement 3 months prior to recruitment

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Tropical Fruits; patient will be consuming the chosen fruits, according to the size of the serving following Malaysian Dietary Guideline 2020	Other: Tropical fruits; papaya, mango, banana, orange
No Intervention: Normal diet; patient will consume normal diet as usual

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
intraocular pressure	tonometer	baseline, at 1 month , at 3 months and 6 months
retinal nerve fibre layer	Spectral domain Cirrus HD-OCT	baseline, at 1 month , at 3 months and 6 months

Collaborators and Investigators

• Sponsor: Hospital Universiti Sains Malaysia
• Collaborators: Universiti Sains Malaysia
• Investigators: Principal Investigator: Nurul Munirah Mohamad, Dr, Department of Ophthalmology School of Medical Sciences Universiti Sains Malaysia,Health Campus.; Study Chair: Liza Sharmini Ahmad Tajudin, Prof. Dr., Department of Ophthalmology School of Medical Sciences Universiti Sains Malaysia,Health Campus.; Study Director: Rohana Abd Jalil, Ass. Prof. Dr., Department of Ophthalmology School of Medical Sciences Universiti Sains Malaysia,Health Campus.; Study Director: Fatimah Suhaila Sukaimy, Dr, Department of Ophthalmology Hospital Tengku Ampuan Afzan, Ministry of Health, Malaysia

Publications and helpful links

General Publications

• Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004 May 22;363(9422):1711-20. doi: 10.1016/S0140-6736(04)16257-0.
• Braakhuis A, Raman R, Vaghefi E. The Association between Dietary Intake of Antioxidants and Ocular Disease. Diseases. 2017 Jan 30;5(1):3. doi: 10.3390/diseases5010003.
• Kang JH, Willett WC, Rosner BA, Buys E, Wiggs JL, Pasquale LR. Association of Dietary Nitrate Intake With Primary Open-Angle Glaucoma: A Prospective Analysis From the Nurses' Health Study and Health Professionals Follow-up Study. JAMA Ophthalmol. 2016 Mar;134(3):294-303. doi: 10.1001/jamaophthalmol.2015.5601.
• Neufeld AH, Sawada A, Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9944-8. doi: 10.1073/pnas.96.17.9944.

Helpful Links

• Primary open-angle glaucoma
• The Association between Dietary Intake of Antioxidants and Ocular Disease. Diseases
• Association of Dietary Nitrate Intake With Primary Open-Angle Glaucoma: A Prospective Analysis From the Nurses' Health Study and Health Professionals Follow-up Study
• Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma

Study record dates

Study Major Dates

• Study Start (Actual): February 1, 2024
• Primary Completion (Estimated): July 1, 2024
• Study Completion (Estimated): July 1, 2025

Study Registration Dates

• First Submitted: October 1, 2023
• First Submitted That Met QC Criteria: October 1, 2023
• First Posted (Actual): October 6, 2023

Study Record Updates

• Last Update Posted (Actual): March 7, 2024
• Last Update Submitted That Met QC Criteria: March 5, 2024
• Last Verified: March 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Eye Diseases; Ocular Hypertension; Glaucoma
• Other Study ID Numbers: RSCH ID-23-03744-7U6

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No